Related Experiment Video

Updated: Jun 20, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle

P W van Duijn1, A C J Ziel-van der Made, J A G van der Korput

  • 1Department of Pathology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, the Netherlands.

The Prostate
|September 29, 2009
PubMed
Abstract

Insights

Restoring PTEN expression in prostate cancer cells inhibits proliferation via cell-cycle arrest. This regulation involves both Akt-dependent and -independent gene expression pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The tumor suppressor PTEN plays a critical role in regulating cellular processes.
  • PTEN inactivation is frequent in prostate cancer, but its precise mechanisms remain unclear.
  • Understanding PTEN's function is crucial for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the impact of regulated PTEN expression on cellular functions and gene expression profiles.
  • To elucidate the downstream signaling pathways affected by PTEN restoration in prostate cancer cells.

Main Methods:

  • Stable transfection of PTEN-negative LNCaP cells with inducible wild-type PTEN (LNCaP/PTEN cells).
  • Microarray analysis to identify gene expression changes upon PTEN induction.
  • Quantitative PCR (Q-PCR) and siRNA experiments to validate gene expression and pathway effects.
  • Flow cytometry for cell-cycle distribution analysis.

Main Results:

  • Induced PTEN expression significantly inhibited LNCaP cell proliferation, primarily through G1 cell-cycle arrest.
  • PTEN induction altered the mRNA expression of G1 cell-cycle regulators: Cdc25a, E2F2, cyclin G2, and RBL2/p130.
  • Akt inhibition mimicked some PTEN effects, downregulating E2F2 and Cdc25a, and upregulating cyclin G2.
  • PTEN-dependent RBL2/p130 mRNA expression was not mediated by Akt signaling.

Conclusions:

  • PTEN-dependent gene expression is vital for cell-cycle regulation in prostate cancer.
  • These regulatory mechanisms involve both Akt-dependent and Akt-independent pathways.
  • Findings provide insights into PTEN's tumor-suppressive functions and potential therapeutic strategies.

More Related Videos

Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...